Opioids

Biotech

Eagle swoops down to nab chunk of BARDA-backed Enalare

Eagle Pharmaceuticals is swooping down to take a chunk out of Enalare Therapeutics, paying up to $55 million in equity to the BARDA-backed company.
Max Bayer Aug 9, 2022 11:22am

Dissolving, nerve-cooling device offers drug-free pain relief

Jul 1, 2022 10:22am

Will addiction tech curb soaring opioid overdose deaths?

Mar 21, 2022 9:15am

FDA OKs Saluda's spinal cord stimulation tech for chronic pain

Mar 9, 2022 10:15am

Pear nabs FDA breakthrough tag for alcoholism digital therapy

Nov 22, 2021 11:55am

Non-opioid pain drug indirectly blocks a key ion channel

Nov 10, 2021 2:00pm